Year: 2025

CALGARY, Alberta, March 11, 2025 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (“Peyto” or the “Company”) is pleased to report operating and financial results for the fourth quarter and 2024 fiscal year, and senior management additions. Full Year and Q4 2024 Highlights:Delivered $199.0 million in funds from operations1,2 (“FFO”), or $1.00/diluted share, and $79.6 million of free funds flow3 in the quarter. Annual FFO totaled $712.8 million or $3.62/diluted share, and annual free funds flow totaled $246.7 million. Annual capital expenditures4 of $457.6 million resulted in record production of 136 Mboe/d (720.7 MMcf/d gas, 15,708 bbl/d NGLs) in December, yielding a trailing 12-month capital efficiency5 of $9,700 boe/d. Peyto booked a record 6.0 Bcfe of Proved Developed Producing...

Reports record full year revenues of $710.6 million and Adjusted EBITDAS of $35.5 million CALGARY, Alberta, March 11, 2025 (GLOBE NEWSWIRE) — FLINT Corp. (“FLINT” or the “Company”) (TSX: FLNT) today announced its results for the three and twelve months ended December 31, 2024. All amounts are in Canadian dollars and expressed in millions of dollars unless otherwise noted. “EBITDAS” and “Adjusted EBITDAS” are not standard measures under IFRS. Please refer to the Advisory regarding Non-GAAP Financial Measures at the end of this press release for a description of these items and limitations of their use. “2024 was the third consecutive year of record annual revenues for FLINT at $710.6 million, representing an increase of 8.4% over 2023. This performance was driven by the advancement of our organic growth strategy across...

Dorel Juvenile revenue increases on market share gains Dorel Home accelerates restructuring program to realign its businessMONTRÉAL, March 11, 2025 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) today announced results for the fourth quarter and the year ended December 30, 2024. Fourth quarter revenue was US$326.8 million, down 6.8%, from US$350.7 million a year ago. Reported net loss for the quarter was US$73.0 million or US$2.24 per diluted share compared to US$3.8 million or US$0.12 per diluted share a year ago. The reported net loss for the quarter includes total restructuring costs of US$14.1 million, and write-downs of deferred tax assets of US$36.5 million. Adjusted net loss1 was US$59.2 million or US$1.82 per diluted share compared to an adjusted net income1 of US$0.2 million or US$0.01 per diluted share...

CHICAGO, March 11, 2025 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its second quarter and first six-months of fiscal year 2025.       Second Quarter Year to Date(in thousands, except per share amounts) Ended January 31, Ended January 31,  2025 2024 Change 2025 2024 ChangeConsolidated Results            Net Sales $ 116,914   $ 105,668     11 % $ 244,859   $ 217,106     13 %Operating Income * $ 17,482   $ 15,165     15 % $ 38,672   $ 28,321     37 %Net Income $ 12,921   $ 12,382     4 % $ 29,297   $ 23,124     27 %EBITDA † $ 22,216   $ 19,233     16 % $ 48,383   $ 36,617     32 %Diluted EPS – Common ‡ $ 0.89   $ 0.85     5 % $ 2.01   $ 1.60     26 %Business to Business            Net Sales $ 43,416   $ 36,234     20 % $ 91,831   $ 75,395     22 %Segment...

Delivers Fourth Quarter Results in Line with and Above Guidance Ranges Provides 2025 Guidance SAN FRANCISCO, March 11, 2025 (GLOBE NEWSWIRE) — Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make better products in a better way, today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 OverviewFourth quarter net revenue decreased 22.4% to $55.9 million versus a year ago, within the Company’s guidance range. Full year net revenue decreased 25.3% to $189.8 million versus a year ago. Fourth quarter gross margin declined approximately 670 basis points to 31.3% versus a year ago; full year gross margin improved approximately 170 basis points to 42.7% versus a year ago. Fourth quarter net loss of $25.7 million,...

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million Company to host conference call and webcast today, Mar. 11, 2025, at 4:30 p.m. ET CELEBRATION, Fla., March 11, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results for the fourth quarter and full year ended Dec. 31, 2024. “2024 was a transformational year for Zevra. We emerged as a commercial stage company and are executing on the opportunity to positively impact the lives of people living with rare diseases,” said Neil F. McFarlane, Zevra’s President and Chief Executive Officer. “We are...